Pharmacy Report Archives - Page 51 of 150 - Becker's Hospital Review

CVS, Walgreens to soon sell abortion pills, OTC birth control | RSV shots might be tied to rare condition | Overused cancer drug costs US $43M per year | CVS settles 27 understaffing cases for $1.5M

March 4, 2024 BHR Newsletter 1. CVS, Walgreens to begin selling abortion pills Full story 2. Retail pharmacies to sell OTC birth control within weeks Full story 3. Where medication abortion is, is not legal Full story 4. Adventist's reenvisioned…

Weight loss drugs bulk up economies | 1 in 3 local pharmacies to close in 2024: Survey | Tetanus vaccine shortage looms | 10 systems seeking pharmacy leaders | Are 8 a.m. meetings back?

February 29, 2024 BHR Newsletter 1. Weight loss drugs wrinkle economies worldwide Full story 2. CDC anticipates shortage of certain tetanus vaccines in 2024 Full story 3. 1 in 3 independent pharmacies to close this year: Survey Full story 4.…

Ozempic's potential rival | PBM probe stalls as AGs demand reforms | 2 drug candidates to know | Neb. hospital fires CEO | Cuban's pharmacy adds 21st branded drug

February 28, 2024 BHR Newsletter 1. A weight loss drug candidate could rival Ozempic Full story 2. PBMs not complying with federal probe: FTC Full story 3. State attorneys general call for federal PBM reforms Full story 4. 90 patients…

1st state OKs drug price ceiling | FDA urged to address Singulair controversy | Surgery surpasses drug outcomes for diabetes | Where Ozempic, AI + layoffs merge | 46 healthcare jobs, ranked

February 27, 2024 BHR Newsletter 1. Surgery better for diabetes than medical, lifestyle changes, 4 systems find Full story 2. New York asks FDA to address Singulair controversy Full story 3. For 1st time, state board sets a drug price…

Change fallout persists | The surgery rising among Ozempic users | Cancer drug approval pulled | 10 systems seeking pharmacy leaders | 1 system's approach to pharmacy tech shortage

February 26, 2024 BHR Newsletter 1. Ozempic patients seek plastic surgery after weight loss Full story 2. 10 systems seeking pharmacy leaders Full story 3. FDA revokes approval of cancer drug Pepaxto Full story 4. 90 patients die every day…

Teens turn to weight loss drugs | 2 drug trials on clinical hold | Hospital CEO's death post-surgery prompts lawsuit | Walgreens' VillageMD to exit Fla. | UAB pauses IVF

February 22, 2024 BHR Newsletter 1. Nearly 4,000 weight loss drug prescriptions in 2023 were for teens Full story 2. FDA places clinical holds on 2 drug studies Full story 3. Walgreens' VillageMD to exit Florida Full story 4. Health systems…

10 new drug shortages | Simplify hiring of foreign pharmacists: AHA | How a CEO handled a $2B mistake | AbbVie names new CEO | 50K syringe pumps might delay therapy | Vizient's 37 customers

February 21, 2024 BHR Newsletter 1. AHA: Simplify hiring process for foreign pharmacists Full story 2. How a CEO handled a $2B mistake Full story 3. 10 drugs now in shortage Full story 4. Healthcare still isn't out of the…

OU Health settles pharmacy lawsuit | Pharmacists, AMA clash over scope | Gene therapies fizzle in execution | Wegovy scripts for kids on the rise | 6 top healthcare billionaires

February 20, 2024 BHR Newsletter 1. Pharmacists confront AMA's 'scope creep' stance Full story 2. OU Health settles pharmacy lawsuit for $140K Full story 3. Buzz for gene therapies is loud, but drugmakers struggle to get treatments off the ground…

Pharmacy execs seeking a promotion: 2 tips | The rise of 'polypharmacy' | A new safety-net designation? | US mulls spring COVID shot | 1st T cell melanoma drug approved

February 19, 2024 BHR Newsletter 1. Pharmacy leaders seeking higher roles: 2 skills to hone Full story 2. The rise of 'polypharmacy' Full story 3. Employers' waning hesitancy over weight loss drugs Full story 4. Faster resolutions on the backend…

FTC probes GPOs, wholesalers | Cuban sells drugs in shortage to hospitals | 10 systems seeking pharmacy leaders | Payer M&A derails | Healthcare layoffs in 14 numbers

February 15, 2024 BHR Newsletter 1. FTC probes whether GPOs, wholesalers cause drug shortages Full story 2. Mark Cuban drug company unveils new offering for hospitals Full story 3. Discontinued asthma drug stirs frustrations Full story 4. Experts are more…